We provide the first evidence to clarify the association between Id-1 overexpression and tumour angiogenesis in human primary cancers and suggest that Id-1 protein may be an important new target molecule for antiangiogenic drugs in cancer treatment. The gene discussed is ID1; the disease is cancer.